{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:27:04Z","timestamp":1793896024339,"version":"4.8.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M752253"],"award-info":[{"award-number":["2024M752253"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1711"],"award-info":[{"award-number":["2025ZNSFSC1711"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3403304"],"award-info":[{"award-number":["2023YFC3403304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3403303"],"award-info":[{"award-number":["2023YFC3403303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073404"],"award-info":[{"award-number":["82073404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403838"],"award-info":[{"award-number":["82403838"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jconrel.2026.115088","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:25:50Z","timestamp":1780961150000},"page":"115088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A macrophage-targeted bivalent saRNA vaccine protects against ocular and cutaneous HSV-1 infection in mice"],"prefix":"10.1016","volume":"396","author":[{"given":"Yanfang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115088_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108099","article-title":"Characterization of resident corneal Plasmacytoid dendritic cells and their pivotal role in herpes simplex keratitis","volume":"32","author":"Jamali","year":"2020","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.disamonth.2014.03.003","article-title":"Herpes simplex keratitis","volume":"60","author":"Hill","year":"2014","journal-title":"Dis. Mon."},{"key":"10.1016\/j.jconrel.2026.115088_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108483","article-title":"Pathobiology and treatment of viral keratitis","volume":"205","author":"Koganti","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2026.115088_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115088_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403961","article-title":"A novel pH-responsive Baicalein@chitosan hydrogel for the topical treatment of herpes simplex virus type 1 skin infections: therapeutic potential and mechanisms","volume":"14","author":"Lu","year":"2025","journal-title":"Adv. Healthc. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0040","doi-asserted-by":"crossref","first-page":"54","DOI":"10.25122\/jml-2024-0377","article-title":"Epidemiological trends of HSV-1 and HSV-2 Central Nervous System Infections: A Retrospective Analysis from 2018 to 2023 from Saudi Arabia","volume":"18","author":"Alhazmi","year":"2025","journal-title":"J. Med. Life"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","article-title":"sup--Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers","volume":"9","author":"Yin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.115088_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmicb.2020.00139","article-title":"Current antivirals and novel botanical molecules interfering with herpes simplex virus infection","volume":"11","author":"\u00c1lvarez","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13010001","article-title":"Advancement on sustained antiviral ocular drug delivery for herpes simplex virus keratitis: recent update on potential investigation","volume":"13","author":"Pandey","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115088_bb0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/OPTH.S80475","article-title":"Herpes simplex keratitis: challenges in diagnosis and clinical management","volume":"11","author":"Azher","year":"2017","journal-title":"Clin. Ophthalmol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115088_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3390\/microorganisms7100429","article-title":"Current and emerging therapies for ocular herpes simplex virus Type-1 infections","volume":"7","author":"Koganti","year":"2019","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115088_bb0070","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.cell.2024.03.018","article-title":"Self-amplifying RNA COVID-19 vaccine","volume":"187","author":"Wayne","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2026.115088_bb0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis","volume":"28","author":"Trougakos","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0080","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41587-024-02306-z","article-title":"Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency","volume":"43","author":"McGee","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"19","key":"10.1016\/j.jconrel.2026.115088_bb0085","doi-asserted-by":"crossref","first-page":"10394","DOI":"10.1128\/JVI.77.19.10394-10403.2003","article-title":"An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector","volume":"77","author":"Perri","year":"2003","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0090","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/d41587-023-00016-6","article-title":"The world\u2019s first CRISPR therapy is approved: who will receive it?","volume":"42","author":"Sheridan","year":"2024","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115088_bb0100","article-title":"Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: a randomized, observer-blind phase 1 study","volume":"4","author":"Akahata","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0105","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0110","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jacs.3c11543","article-title":"Chemical synthesis creates single Glycoforms of the Ectodomain of herpes simplex Virus-1 glycoprotein D","volume":"146","author":"Zhao","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.115088_bb0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2023.11.026","article-title":"Targeted delivery of herpes simplex virus glycoprotein D to CD169+ macrophages using ganglioside liposomes alleviates herpes simplex keratitis in mice","volume":"365","author":"Shen","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03887-24","article-title":"Herpes simplex virus type 1 impairs mucosal-associated invariant T cells","volume":"16","author":"Stern","year":"2025","journal-title":"mBio"},{"issue":"13","key":"10.1016\/j.jconrel.2026.115088_bb0125","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1128\/JVI.00788-15","volume":"89","author":"Khan","year":"2015","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.jconrel.2026.115088_bb0130","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D\u2013adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"Belshe","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.115088_bb0140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fimmu.2020.00766","article-title":"Pathogenesis of herpes stromal keratitis: immune inflammatory response ediated by inflammatory regulators","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/514049","article-title":"Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice","volume":"176","author":"Keadle","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/infdis\/jiu177","article-title":"Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine","volume":"210","author":"Awasthi","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0155","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-024-00199-7","article-title":"A review of HSV pathogenesis, vaccine development, and advanced applications","volume":"5","author":"Bai","year":"2024","journal-title":"Mol. Biomed."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115088_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00006-24","article-title":"The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis. Forrest GN, ed","volume":"37","author":"Antony","year":"2024","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115088_bb0170","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S1470-2045(22)00372-2","article-title":"Clinical advances and ongoing trials of mRNA vaccines for cancer treatment","volume":"23","author":"Lorentzen","year":"2022","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2026.115088_bb0180","first-page":"31","article-title":"Vaccines for herpes simplex: recent progress driven by viral and adjuvant immunology, Herpes Simplex","volume":"2060","author":"Sandgren","year":"2019","journal-title":"Virus"},{"issue":"8045","key":"10.1016\/j.jconrel.2026.115088_bb0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41586-024-08291-2","article-title":"Placenta-tropic VEGF mRNA lipid nanoparticles ameliorate murine pre-eclampsia","volume":"637","author":"Swingle","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.115088_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/br.2020.1402","article-title":"Functions of CD169 positive macrophages in human diseases (review)","volume":"14","author":"Liu","year":"2020","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.jconrel.2026.115088_bb0200","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3389\/fimmu.2018.01997","article-title":"Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma","volume":"9","author":"Van Dinther","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0205","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.celrep.2018.01.021","article-title":"Functional CD169 on macrophages mediates interaction with dendritic cells for CD8+ T cell cross-priming","volume":"22","author":"Van Dinther","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chembiol.2018.10.006","article-title":"Targeted delivery of antigen to activated CD169+ macrophages induces Bias for expansion of CD8+ T cells","volume":"26","author":"Edgar","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039039","article-title":"Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin\/CD169","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0220","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.imbio.2016.11.013","article-title":"Comparative analysis of the internalization of the macrophage receptor sialoadhesin in human and mouse primary macrophages and cell lines","volume":"222","author":"De Schryver","year":"2017","journal-title":"Immunobiology"},{"key":"10.1016\/j.jconrel.2026.115088_bb0225","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3389\/fimmu.2018.02472","article-title":"CD169+ macrophages capture and dendritic cells instruct: the interplay of the gatekeeper and the general of the immune system","volume":"9","author":"Grabowska","year":"2018","journal-title":"Front. Immunol."},{"issue":"44","key":"10.1016\/j.jconrel.2026.115088_bb0230","doi-asserted-by":"crossref","first-page":"27528","DOI":"10.1073\/pnas.2006186117","article-title":"Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes","volume":"117","author":"Affandi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2026.115088_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jconrel.2021.01.029","article-title":"Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion","volume":"331","author":"Grabowska","year":"2021","journal-title":"J. Control. Release"},{"issue":"19","key":"10.1016\/j.jconrel.2026.115088_bb0240","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1073\/pnas.1201104109","article-title":"HIV-1 incorporation of host-cell\u2013derived glycosphingolipid GM3 allows for capture by mature dendritic cells","volume":"109","author":"Puryear","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1073\/pnas.0909541107","article-title":"Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells","volume":"107","author":"Backer","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115088_bb0250","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/pharmaceutics12121138","article-title":"Optimization of liposomes for antigen targeting to splenic CD169+ macrophages","volume":"12","author":"Nijen Twilhaar","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0255","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acsnano.5b06501","article-title":"Lipid-mediated targeting with membrane-wrapped nanoparticles in the presence of Corona formation","volume":"10","author":"Xu","year":"2016","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0260","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1021\/acsami.1c17415","article-title":"Virus-mimicking polymer nanoparticles targeting CD169+ macrophages as long-acting Nanocarriers for combination Antiretrovirals","volume":"14","author":"Eshaghi","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"757","key":"10.1016\/j.jconrel.2026.115088_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm8451","article-title":"Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70","volume":"16","author":"Brook","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"104","key":"10.1016\/j.jconrel.2026.115088_bb0270","doi-asserted-by":"crossref","first-page":"eado5937","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"Ben-Akiva","year":"2025","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.115088_bb0275","doi-asserted-by":"crossref","DOI":"10.1101\/2024.12.29.630334","article-title":"Controlling reactogenicity while preserving immunogenicity from a self-amplifying RNA vaccine by modulating nucleocytoplasmic transport","author":"Wojcechowskyj","year":"2024","journal-title":"Immunology"},{"issue":"824","key":"10.1016\/j.jconrel.2026.115088_bb0280","doi-asserted-by":"crossref","first-page":"eadz2276","DOI":"10.1126\/scitranslmed.adz2276","article-title":"Incorporation of 5-methylcytidine alleviates RIG-I\u2013mediated innate immune responses to a self-amplifying RNA vaccine","volume":"17","author":"Akahata","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0285","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","article-title":"Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0290","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1038\/s41598-026-44645-8","article-title":"Heterologous saRNA prime \u2013 multivalent protein boost strategy induces broad and durable immunity against SARS-CoV-2 and MERS-CoV","volume":"16","author":"Renn","year":"2026","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115088_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2026.111042","article-title":"Development of a DC-targeting Salmonella- amplifying RNA vector platform co-delivering dual antigens and adjuvants for enhanced protection against H9N2 avian influenza","volume":"318","author":"Wang","year":"2026","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.jconrel.2026.115088_bb0300","first-page":"189","article-title":"Iterative selection of lipid nanoparticle vaccine adjuvants for rapid elicitation of tumoricidal CD8+ T cells","volume":"48","author":"Luo","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.115088_bb0305","doi-asserted-by":"crossref","DOI":"10.1101\/2024.07.29.605626","article-title":"An IL-12 mRNA-LNP adjuvant enhances mRNA vaccine induced CD8+ T cell responses","author":"Aunins","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0310","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.iy.13.040195.001343","article-title":"Interleukin-12: a Proinflammatory cytokine with Immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity","volume":"13","author":"Trinchieri","year":"1995","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115088_bb0315","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/jvi.69.8.4898-4905.1995","article-title":"Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1","volume":"69","author":"Cantin","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.115088_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112428","article-title":"Overexpression of NLRP12 enhances antiviral immunity and alleviates herpes simplex keratitis via pyroptosis\/IL-18\/IFN-\u03b3 signaling","volume":"137","author":"Jiang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0325","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymthe.2025.12.018","article-title":"An IL-12 renaissance: engineering tumor-restricted IL-12 to improve solid tumor T cell therapies","volume":"34","author":"Ishihara","year":"2026","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115088_bb0330","first-page":"882","article-title":"Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Can."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115088_bb0335","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.ymthe.2024.10.016","article-title":"Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant","volume":"32","author":"Laghlali","year":"2024","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0340","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: phantom or reality?","volume":"12","author":"Su","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12035-025-05512-1","article-title":"IL-12 ameliorates diabetic retinal neurodegeneration by activating microglial phagocytosis via the TREM2\/DAP12 pathway","volume":"63","author":"Fang","year":"2026","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0350","article-title":"Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0355","doi-asserted-by":"crossref","first-page":"336","DOI":"10.12982\/BSCM.2025.28","article-title":"Comprehensive strategies for overcoming barriers in ocular drug delivery: current trends and future directions","volume":"64","author":"Department of Pharmaceutics, Sri Balaji Vidhyapeeth Deemed University, Pondicherry, India","year":"2025","journal-title":"Biomed. Sci. Clin. Med."},{"key":"10.1016\/j.jconrel.2026.115088_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113970","article-title":"Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function","volume":"385","author":"Park","year":"2025","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115088_bb0365","first-page":"6397","article-title":"The safety of retinal viral gene therapy routes: a meta-analysis","volume":"66","author":"Johnson","year":"2025","journal-title":"Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.115088_bb0370","unstructured":"Lipid Nanoparticle-Mediated Delivery of mRNA into the Mouse and Human Retina and other Ocular Tissues. 07.13.548758v1. 2026."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115088_bb0375","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3390\/bioengineering12101122","article-title":"Surgical approaches to retinal gene therapy: 2025 update","volume":"12","author":"Patel","year":"2025","journal-title":"Bioengineering"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115088_bb0380","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.3390\/ijms25094755","article-title":"Vaccines and the eye: current understanding of the molecular and immunological effects of vaccination on the eye","volume":"25","author":"Zou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115088_bb0385","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/vaccines13080829","article-title":"Nasal and ocular immunization with bacteriophage virus-like particle vaccines elicits distinct systemic and mucosal antibody profiles","volume":"13","author":"Jamus","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.jconrel.2026.115088_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114027","article-title":"Efficacy versus immunogenicity of LNP-mediated delivery of mRNA and self-amplifying RNA upon intravitreal injection in the mouse eye","volume":"385","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0395","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/bioengineering9010041","article-title":"Targeting ocular drug delivery: an examination of local anatomy and current approaches","volume":"9","author":"Dosmar","year":"2022","journal-title":"Bioengineering"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0400","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ymthe.2021.04.001","article-title":"A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice","volume":"29","author":"De Alwis","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115088_bb0405","doi-asserted-by":"crossref","DOI":"10.1101\/2024.08.23.609366","article-title":"Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2","author":"Singh","year":"2024","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0410","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ymthe.2022.10.011","article-title":"Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection","volume":"31","author":"Kr\u00e4hling","year":"2023","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0415","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2018.10.002","article-title":"Pathogenesis of herpes simplex keratitis: the host cell response and ocular surface sequelae to infection and inflammation","volume":"17","author":"Lobo","year":"2019","journal-title":"Ocul. Surf."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0420","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/21691401.2017.1313262","article-title":"Enhanced acyclovir delivery using w\/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection","volume":"46","author":"Kaur","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115088_bb0425","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/vaccines13030330","article-title":"Exploring CD169+ macrophages as key targets for vaccination and therapeutic interventions","volume":"13","author":"Bouma","year":"2025","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115088_bb0430","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob. Health"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0435","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/v14050862","article-title":"Fraternal twins: the enigmatic role of the immune system in Alphaherpesvirus pathogenesis and latency and its impacts on vaccine efficacy","volume":"14","author":"Rouse","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09286586.2021.1962919","article-title":"Incidence of herpes simplex virus keratitis and other ocular disease: global review and estimates","volume":"29","author":"McCormick","year":"2022","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.jconrel.2026.115088_bb0445","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2021.12.006","article-title":"An mRNA vaccine to prevent genital herpes","volume":"242","author":"Awasthi","year":"2022","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0450","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s44263-024-00053-6","article-title":"Estimated global and regional economic burden of genital herpes simplex virus infection among 15\u201349 year-olds in 2016","volume":"2","author":"Chaiyakunapruk","year":"2024","journal-title":"BMC Glob. Public Health"},{"key":"10.1016\/j.jconrel.2026.115088_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.918346","article-title":"Pathophysiological significance of GM3 ganglioside molecular species with a particular attention to the metabolic syndrome focusing on toll-like receptor 4 binding","volume":"9","author":"Inokuchi","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115088_bb0460","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1074\/jbc.M111669200","article-title":"Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides","volume":"277","author":"Miljan","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2\u20134","key":"10.1016\/j.jconrel.2026.115088_bb0465","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s12177-008-9010-6","article-title":"Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation","volume":"1","author":"Hori","year":"2008","journal-title":"J. Ocul. Biol. Dis. Infor."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115088_bb0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41433-024-03512-4","article-title":"Evolution of the ocular immune system","volume":"39","author":"Forrester","year":"2025","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2026.115088_bb0475","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jconrel.2022.11.045","article-title":"Enhanced immune responses to vaccine antigens in the corneal stroma","volume":"353","author":"Xia","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115088_bb0480","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archophthalmol.2009.352","article-title":"Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery","volume":"128","author":"Cardillo","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0490","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12886-023-02943-z","article-title":"Modified-dropless protocol (nil intraocular) for micro-incision vitrectomy surgery (MIVS): a retrospective pilot study","volume":"23","author":"Garcia-O\u2019Farrill","year":"2023","journal-title":"BMC Ophthalmol."},{"issue":"08","key":"10.1016\/j.jconrel.2026.115088_bb0495","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1055\/a-2349-2224","article-title":"Anterior segment complications following intravitreal injection","volume":"241","author":"Mackenbrock","year":"2024","journal-title":"Klin. Monatsbl. Augenheilkd."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115088_bb0500","article-title":"A case series of serious adverse events following anti-VEGF intravitreal injections","volume":"69","year":"2025","journal-title":"Romanian J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115088_bb0505","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/eye.2017.158","article-title":"Technique of retinal gene therapy: delivery of viral vector into the subretinal space","volume":"31","author":"Xue","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.jconrel.2026.115088_bb0510","author":"Current Subretinal Gene Therapy Delivery"},{"key":"10.1016\/j.jconrel.2026.115088_bb0515","series-title":"A Therapeutic Vaccine That Reduces Recurrent Herpes Simplex Virus Type 1 Corneal Disease","author":"Nesburn","year":"2026"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115088_bb0520","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ICU.0000000000001136","article-title":"Evaluating the necessity of topical and subconjunctival antibiotic prophylaxis in ocular surgery","volume":"36","author":"Chawla","year":"2025","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115088_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/0004-2749.2024-0394","article-title":"Perioperative subconjunctival steroid injection in dropless cataract surgery: a systematic review and meta-analysis","volume":"88","author":"Cyrino","year":"2025","journal-title":"Arq. Bras. Oftalmol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115088_bb0530","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.4285\/ATW2023.F-9061","article-title":"Modulation of immunosuppression for long-term graft survival in lamellar pig-to-monkey corneal xenotransplantation from the genetically engineered pig model","volume":"37","author":"Shin","year":"2023","journal-title":"Korean J. Transplant."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115088_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100492","article-title":"Suppression of neovascularization by topical and subconjunctival bevacizumab after high-risk corneal transplantation","volume":"4","author":"Dohlman","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.jconrel.2026.115088_bb0540","article-title":"Subconjunctival dexamethasone implant (Ozurdex) for peripheral ulcerative keratitis","volume":"39","author":"Ghoraba","year":"2025","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.jconrel.2026.115088_bb0545","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jtos.2025.05.009","article-title":"Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease \u2013 a phase 1b clinical trial","volume":"38","author":"Tu","year":"2025","journal-title":"Ocul. Surf."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926004918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:00:05Z","timestamp":1793894405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926004918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":109,"alternative-id":["S0168365926004918"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115088","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A macrophage-targeted bivalent saRNA vaccine protects against ocular and cutaneous HSV-1 infection in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115088"}}